The clinical and histological characteristics and outcomes of drug induced chronic liver injury after removing causative drugs

Hepato-Gastroenterology

Volumn 57, Issue 99-100, 2010, Pages 554-561

  Hou, Feng Qin ^a   Wang, Tai Ling ^b   Liu, Xia ^b   Huo, Na ^a   Wang, Gui Qiang ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

^b CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

Author keywords

Chronic liver injury; Drugs

Indexed keywords

ACICLOVIR; AMINOPHENAZONE; AMLODIPINE BESYLATE; AMOXICILLIN; BEZAFIBRATE; CEFALEXIN; CEFRADINE; DIAZEPAM; DIETHYLSTILBESTROL; ETHAMBUTOL; FOSINOPRIL; GLIQUIDONE; HERBACEOUS AGENT; ISONIAZID; METRONIDAZOLE; MEVINOLIN; MIRTAZAPINE; NORETHISTERONE; NORFLOXACIN; OZAGREL; PARACETAMOL; PROPYLTHIOURACIL; PYRAZINAMIDE; RIFAMPICIN; ROXITHROMYCIN; SIMVASTATIN; UROKINASE;

ACUTE ICTERIC HEPATITIS; ADOLESCENT; ADULT; AGED; ARTICLE; BILE DUCT DISEASE; BILE DUCT INJURY; BILIARY CIRRHOSIS; CELL INFILTRATION; CELL INFLAMMATION; CENTROLOBULAR BIRDGE NECROSIS; CENTROLOBULAR NECROSIS; CENTROLOBULAR SPOTS NECROSIS; CHOLANGITIS; CHOLESTASIS; CHRONIC DISEASE; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DUCTOPENIA; EOSINOPHIL INFILTRATION; FEMALE; FIBROSIS; FOLLOW UP; HEPATITIS; HUMAN; INFLAMMATION; LIVER BIOPSY; LIVER CELL DAMAGE; LIVER CIRRHOSIS; LIVER INJURY; MALE; MULTILOBULAR NECROSIS; NECROSIS; OUTCOME ASSESSMENT; PORTAL FIBROSIS; PRIORITY JOURNAL; SIDE EFFECT; SPOTS NECROSIS; SUBMASSIVE NECROSIS; TREATMENT OUTCOME; VANISHING BILE DUCT SYNDROME;

ADOLESCENT; ADULT; AGED; CHOLESTASIS; DRUG-INDUCED LIVER INJURY, CHRONIC; FEMALE; HUMANS; LIVER; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 77955508624     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Sgro C, Clinard F, Ouazir K, et al: Incidence of drug induced hepatic injuries: a French population-based study. Hepatology 2002; 36:451-5.
2. Ibanez L, Perez E, Vidal X, Laporte JR: Grup d'Estudi Multicenteric d'Hepatotoxicitat Aguda de Barcelona (GEMHAB): Prospective surveillance of acute serious liver disease unrelated to infectious, obstructive, or metabolic diseases: epidemiological and clinical features, and exposure to drugs. J Hepatol 2002; 37:592-600.
3. Ahmad, S. R: Adverse drug event monitoring at the Food and Drug Administration. Your report can make a difference. J Gen Intern Med 2003; 18:57-60.
4. Ostapowicz G, Fontana RJ, Schiødt FV, et al: Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 2002; 137:947-54.
5. Russo MW, Galanko JA, Shrestha R, Fried MW, Watkins P: Liver transplantation for acute liver failure from drug induced liver injury in the United States. Liver Transpl 2004; 10:1018-23.
6. Goodman, Z. D: Drug hepatotoxicity. Clin Liver Dis 2002;6:381-97.
7. Kaplowitz N: Drug induced liver disorders: Implications for drug development and regulation. Drug Saf 200;24:483-490.
8. Oikawa H, Maesawa C, Sato R, et al: Liver cirrhosis induced by long-term administration of a daily low dose of amiodarone: a case report. World J Gastroenterol 2005;11:5394-5397.
9. Andrade RJ, Lucena MI, Kaplowitz N, et al: Outcome of Acute Idiosyncratic Drug induced Liver Injury: Long-Term Follow-up in a Hepatotoxicity Registry. Hepatology 2006; 44:1581-1588.
10. Björnsson E, Kalaitzakis E, Av Klinteberg V, Alem N, Olsson R: Long-term follow-up of patients with mild to moderate drug induced liver injury. Aliment Pharmacol Ther 2007; 26:79-85.
11. Aithal PG, Day CP: The natural history of histologically proved drug induced liver disease. Gut 1999; 44:731-735.
12. Levy C, Lindor KD: Drug induced cholestasis. Clin Liver Dis 2003; 7:311-30.
13. Davies MH, Harrison RF, Elias E, Hubscher SG: Antibiotic-associated acute vanishing bile duct syndrome: a pattern associated with severe, prolonged, intrahepatic cholestasis. J Hepatol 1994; 20:112-6.
14. Danan G, Benichou C: Causality assessment of adverse reactions to drugs - I. A novel method based on the conclusions of international consensus meetings: application to drug induced liver injuries. J Clin Epidemiol 1993; 46:1323-1330.
15. Benichou C: Report of an International Consensus Meeting. Criteria of drug induced liver disorders. J Hepatol 1990; 11:272-276.
16. World Health Organisation Collaborating Centre for Drugs Statistics Methodology: Anatomical Therapeutic Chemical (ATC) Classification Index Including Defined Daily Dose (DDDs) for Plain Substances. Oslo: World Health Organization Collaborating Centre for drugs statistics methodology, 2002.
17. Marydee C. Chamberlain, Sarah Jane Schwarzenberg, Evren U. Akin, and Margaret Heisel Kurth: Minocycline-Induced Autoimmune Hepatitis with Subsequent Cirrhosis. J Pediatr Gastroenterol Nutr 2006; 42:232-235.
18. Pineda JA, Larrauri J, Macias J, et al: Rapid progression to liver cirrhosis of toxic hepatitis due to ebrotidine. J Hepatol 1999; 31:777-778.
19. Wai C T: Presentation of drug induced liver injury in Singapore. Singapore Med J 2006; 47:116-120.
20. De Valle MB, Av Klinteberg V, Alem N, Olsson R, Björnsson E: Drug induced liver injury in a Swedish University hospital out-patient hepatology clinic. Aliment Pharmacol Ther 2006; 24:1187-1195.